Overview

The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study changes in skin color that may be caused by using one of the three eye medicines: Xalatan, Travatan or Lumigan.
Phase:
Phase 4
Details
Lead Sponsor:
Summa Health System
Treatments:
Bimatoprost
Latanoprost
Ophthalmic Solutions
Travoprost